Clinton Health Access Initiative Inc is a 501(c)(3) organization based in Boston, Massachusetts, registered in 2010, with $246,122,771 in FY2024 revenue. CharityIndex grades it B, and it directs about 91% of spending to programs.
Revenue (FY2024)
$246.1M
▲ 9.6% vs prior year
International median: $227K
Expenses (FY2024)
$243.6M
Net assets
$13.5M
Employees
197
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Clinton Health Access Initiative Inc: 91% to programs · $1 to raise $100 earns a C+ on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Clinton Health Access Initiative Inc: 1 mo reserves · +1% margin earns a C+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Clinton Health Access Initiative Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Clinton Health Access Initiative Inc: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
The clinton health access initiative, inc. (chai) is a global health organization that envisions a world in which everyone is able to live a healthy and fulfilling life. we are committed to saving lives and improving health outcomes by enabling the government and private sector to strengthen and sustain quality health systems.
Women and children's health: see schedule o for continuationwomen and children suffer the greatest burden from disease globally. chai has significantly increased access to recommended treatments for diarrhea and pneumonia, the largest killers of children under five; made critical vaccines that protect against childhood illnesses more affordable; is combatting chronic malnutrition; and is dramatically and sustainably reducing maternal and newborn deaths and providing access to women's health services.for example, when chai began our diarrhea program in 2012, only one-third of children that needed lifesaving oral rehydration solutions (ors) received it. zinc usage rates were even worse. through chai's market shaping work, we helped reduce the average cost of zinc/ors treatment by 42 percent. working with partners in india, kenya, nigeria, and uganda, we also increased the percentage of children with diarrhea receiving zinc/ors from less than one percent to 24 percent.another strong example is chai's work to save the lives of women and newborns. chai has developed an integrated, women and newborn, health strategy that has contributed to sustained and signficant reductions in death in countries where we work. this approach was first piloted in ethiopia, before being tested at scale in nigeria, where we saw a nearly 40 percent reduction in maternal mortality and a 43 percent reduction in newborn deaths in a 12- month period in target states of northern nigeria. the program has been rolled out more recently in zambia and uganda with similar results.
Achieving universal coverage: see schedule o for continuationchai's founding mission and ultimate goal is to help countries create high-quality, sustainable healthcare systems. to achieve this, we work with governments to strengthen national financing systems and to build sufficient physical infrastructure to deliver health services. through this work chai has supported governments to secure over $4 billion for health systems strengthening, improved data based decision making, increased system efficiencies, and reduced costs.
Non-communicable diseases:non-communicable diseases (ncds) such as heart disease, cancer, chronic respiratory disease, and diabetes are the leading cause of death globally, exceeding all communicable disease deaths combined. in addition to our ncd program, which supports governments to strengthen and implement their ncd prevention and control strategies, chai is partnering with governments to strengthen cancer care systems by solving critical systemic gaps. we believe by working in close collaboration with partner governments and by anchoring a suite of transformational interventions, we can dramatically improve survival rates of cancer patients in low- and middle-income countries.cross-cutting experts: chai works with governments and companies around the world to fundamentally change the economics of global health. using a holistic, business-minded approach to secure lower prices for key commodities such as medication and diagnostics, improve laboratories, and connect decision-makers with the high-quality evidence they need to inform health policy in low- and middle-income countries, chai helps patients access the care and treatment they need. our science and business experts work across the organization to support our program and country teams. chai works on both the supply and demand sides of the market to lower costs and increase availability of the best health products for low-and middle-income countries. working with the public and private sectors, we help shape markets and realize savings for drugs, devices, and diagnostics in all areas of our work. chai has negotiated over 140 global agreements to lower the prices of critical medications and other health tools by 50-90 percent. twenty-seven million people living with hiv have been reached by one such agreement lowering the cost of the optimal hiv treatment tld, a savings of over $500 million. through the g
Revenue grew from $117.4M (FY2013) to $246.1M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
1.0%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$177.2M
Total liabilities
$163.7M
Net assets
$13.5M
Salaries & benefits
$118.6M
49% of expenses
Board members
14
14 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $246,122,771▲9.6% | $243,617,406▲8.0% | $13,531,230▲22.7% | $177,238,535▲10.3% | 990 |
| 2023 | $224,653,300▼0.2% | $225,603,286▼0.1% | $11,026,839▼7.9% | $160,736,489▲14.5% | 990 |
| 2022 | $225,088,441▲2.1% | $225,929,349▲3.7% | $11,976,825▼6.6% | $140,374,789▲5.8% | 990 |
| 2021 | $220,434,799▲11.3% | $217,818,438▲9.6% | $12,817,733▲25.6% | $132,736,927▲13.9% | 990 |
| 2020 | $198,087,254▲4.2% | $198,671,545▲6.0% | $10,201,372▼5.4% | $116,560,796▲13.9% | 990 |
| 2019 | $190,037,689▲7.8% | $187,496,062▲18.1% | $10,785,663▼85.1% | $102,370,576▼3.4% | 990 |
| 2018 | $176,278,231▲38.2% | $158,768,452▲17.7% | $72,428,163▲31.2% | $105,927,123▲27.8% | 990 |
| 2017 | $127,550,776▼10.8% | $134,936,532▼3.6% | $55,204,982▼11.8% | $82,858,248▼8.7% | 990 |
| 2016 | $142,953,258▼16.3% | $139,913,360▼7.2% | $62,590,738▲5.1% | $90,764,479▼4.7% | 990 |
| 2015 | $170,835,442▲20.6% | $150,817,476▲9.0% | $59,558,702▲50.8% | $95,237,284▲11.7% | 990 |
| 2014 | $141,696,956▲20.7% | $138,346,274▲29.9% | $39,487,319▲9.0% | $85,249,750▲2.4% | 990 |
| 2013 | $117,439,074 | $106,491,333▲38.4% | $36,218,514▲42.5% | $83,246,819▲20.9% | 990 |
| 2012 | — | $76,970,166▲16.6% | $25,424,213▲83.5% | $68,838,138▲31.5% | 990 |
| 2011 | — | $66,007,027▼5.1% | $13,852,572▼9.0% | $52,362,846▼53.8% | 990 |
| 2010 | — | $69,565,835 | $15,222,315 | $113,424,316 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Dr Neil Buddy Shah — $532,048 (0.22% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Dr Neil Buddy Shah | Chief Executive Officer | 40 | $532,048 |
| Rasha Hibri | Chief Financial Officer | 40 | $407,213 |
| Joshua Chu | Chief Operating Officer | 40 | $352,018 |
| David Ripin | Evp, Infectious Diseases/cso | 40 | $312,861 |
| Zachary Katz | Vp, Child Health | 40 | $263,847 |
| Yann Le Tallec | Sr. Director, Vaccines | 40 | $227,380 |
| Dr Olufunke Fasawe | Vp, Integrations, Cd | 40 | $223,376 |
| Raphael Hurley | Sr. Director, Health Financing | 40 | $220,755 |
| Samantha Diamond | Vp, Health Systems & Ncds | 40 | $218,873 |
| Gerald Macharia | Vp, East & Southern Africa/country | 40 | $218,175 |
| Justin Cohen | Vp, Global Malaria & Ntds | 40 | $217,628 |
| Paul Domanico | Global Health Research Fellow | 40 | $216,749 |
| Carolyn Amole | Vp, Hiv, Hepatitis and Tb | 40 | $206,746 |
| Neel Lakhani | Vp, Innovation | 40 | $204,053 |
| Caitlin Glover | Vp, Women & Newborn Health | 40 | $199,963 |
| Trevor Peter | Sr. Director, Global Diagnostics | 40 | $194,652 |
| Dr Rahel Belete | Vp, Cd | 40 | $177,287 |
| Alan Schwartz | Board Member | 1 | — |
| Aliko Dangote | Board Member | 1 | — |
| Ann Veneman | Board Member | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| Global Human Access Resources Limited | Information Systems | $474,869 |
| Lubombo Spatial Development Initiative | Programmatic Support | $405,000 |
| White Coral Consulting Dmmc | Employment Management | $333,928 |
| Pt Mahakarya Adi Indonesia | Digital Innovation | $324,729 |
| Aman Siwach F-3 | Programmatic Support | $253,700 |
79 grants to Clinton Health Access Initiative Inc totaling $102.4M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Silicon Valley Community Foundation | International development | 2024 | $13,848,599 |
| Gavi Alliance | Partner support | 2024 | $12,569,078 |
| The Clear Fund | Tuberculosis | 2024 | $4,500,000 |
| Breakthrough T1d | T1d research | 2024 | $1,734,554 |
| The Clear Fund | Ors/zinc | 2024 | $1,179,836 |
| Population Services International | Malaria | 2024 | $385,294 |
| United Nations Foundation Inc | Global hlth | 2024 | $150,000 |
| United Nations Foundation Inc | Global hlth | 2024 | $150,000 |
| Vital Strategies Inc | Data for health | 2024 | $77,147 |
| Gavi Alliance | Partner support | 2023 | $5,763,165 |
| Family Health International | Global health | 2023 | $5,043,693 |
| The Clear Fund | Ors/zinc | 2023 | $5,030,041 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $2,100,000 |
| Jsi Research & Training Institute Inc | Operational support | 2023 | $1,978,946 |
| Follow Your Dream Foundation Inc | General support | 2023 | $1,121,445 |
25 grants totaling $5.7M in FY2024 — showing the 15 largest. All grants made by Clinton Health Access Initiative Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| Pathfinder International | Health | $903,858 |
| Population Services International | Health | $673,595 |
| Interchurch Medical Assistance Inc | Health | $650,872 |
| Innovations For Poverty Action | Health | $530,387 |
| Ipas | Health | $459,885 |
| Engenderhealth Inc | Health | $349,907 |
| Catholic Relief Services | Health | $344,914 |
| Johns Hopkins University | Health | $324,829 |
| Family Health International | Health | $228,501 |
| Path | Health | $191,159 |
| Elizabeth Glaser Pediatric Aids Foundation | Health | $180,697 |
| Talamus Health Inc | Health | $177,342 |
| Trustees of Columbia University | Health | $171,190 |
| Rand Corporation | Health | $156,245 |
| Malaria No More Fund | Health | $108,952 |
Explore more
Data for Clinton Health Access Initiative Inc (EIN 27-1414646) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.